MPH MITTELSTAENDISCHE PHARMA HOLDING AG March 16, 2015
MPH Mittelständische Pharma Holding AG: Preliminary IFRS results 2014, sales of EUR 219.24 million, net income of EUR 8.46 millionMPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0NF697), reports its preliminary IFRS Group results for the financial year 2014.
In the financial year 2014 the preliminary IFRS Group sales amounted to approximately EUR 219.24 million (previous year: EUR 226.84 million) and the preliminary IFRS consolidated net income was about EUR 8.46 million (previous year: EUR 7.49 million). The preliminary earnings per share reached EUR 0.19 (previous year: EUR 0.18).
The substance has been further strengthened. The preliminary IFRS equity increased to EUR 94.73 million (previous year: EUR 79.19 million). The liquidity position improved to EUR 10.12 million (previous year: EUR 5.85 million).
The business strategy of "making a contribution towards maintaining healthcare affordable" has paid off. In the healthcare market MPH AG is following this strategy with an attractive offer of medicines and medical services with focus on oncology and HIV in the health insurance reimbursed market and with focus on aesthetic medicine in the self-pay market.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth segments Pharma and
Healthcare. The pharmaceutical sector makes a contribution towards cutting
costs in the healthcare system with medicines manufactured on the basis of patent-free and patent-protected active substances for the therapy of chronic diseases. The field of healthcare offers healthcare preparations, individual patient therapies, aesthetic surgeries and other medical treatments.
Key figures for the share of MPH Mittelständische Pharma Holding AG: Subscribed capital: EUR 42,813,842
Listed shares: ordinary shares
ISIN: DE000A0L1H32
WKN: A0L1H3
Stock symbol: 93M
MPH Mittelständische Pharma Holding AG Linda Reichelt
Fasanenstraße 77 Phone: +49 (0) 30 897 30 86 60 E-Mail: ir@mph-ag.de
D-10623 Berlin Fax: +49 (0) 30 897 30 86 69 Web: www.mph-ag.de
Corporate NewsMarch 16, 2015
Contact: Linda Reichelt
MPH Mittelständische Pharma Holding AG Fasanenstraße 77
D-10623 Berlin
Phone:+49 (0) 30 897308660 Fax:+49 (0) 30 897308669
E-Mail: ir@mph-ag.deWeb: www.mph-ag.de
MPH Mittelständische Pharma Holding AG Linda Reichelt
Fasanenstraße 77 Phone: +49 (0) 30 897 30 86 60 E-Mail: ir@mph-ag.de
D-10623 Berlin Fax: +49 (0) 30 897 30 86 69 Web: www.mph-ag.de
|
distributed by
|
